# Actelion Pharmaceuticals CZ

> former Czech company

**Wikidata**: [Q101063379](https://www.wikidata.org/wiki/Q101063379)  
**Source**: https://4ort.xyz/entity/actelion-pharmaceuticals-cz

## Summary
Actelion Pharmaceuticals CZ was a former Czech pharmaceutical company headquartered in Prague, operating as a limited liability entity (společnost s ručením omezeným) from its inception on November 30, 2009, until its dissolution in 2019. It was a subsidiary or affiliate of the broader Actelion Pharmaceuticals network and was later succeeded by Janssen-Cilag, a Johnson & Johnson subsidiary.

## Key Facts
- **Inception Date:** November 30, 2009.
- **Dissolution Date:** 2019.
- **Legal Form:** společnost s ručením omezeným (limited liability company).
- **Headquarters:** Prague, Czech Republic (Francouzská 28, 120 00).
- **Official Name:** Actelion Pharmaceuticals CZ, s.r.o.
- **Czech Registration ID (IČO):** 28998871.
- **OpenCorporates ID:** cz/28998871.
- **Ringgold ID:** 56745.
- **Followed By:** Janssen-Cilag.
- **Instance Of:** Business (organization undertaking commercial, industrial, or professional activity).
- **Country:** Czech Republic.
- **Wikidata Description:** Former Czech company.

## FAQs

**What was Actelion Pharmaceuticals CZ?**
Actelion Pharmaceuticals CZ was a Czech-based pharmaceutical company that operated as a limited liability entity from 2009 to 2019. It was part of the broader Actelion Pharmaceuticals network and was headquartered in Prague.

**When was Actelion Pharmaceuticals CZ founded and dissolved?**
The company was officially established on November 30, 2009, and ceased operations in 2019, after which it was succeeded by Janssen-Cilag.

**Where was Actelion Pharmaceuticals CZ located?**
The company was headquartered in Prague, Czech Republic, at the address Francouzská 28, 120 00.

**What was the legal structure of Actelion Pharmaceuticals CZ?**
It operated as a společnost s ručením omezeným, which translates to a limited liability company under Czech law.

**What happened to Actelion Pharmaceuticals CZ after its dissolution?**
Following its dissolution in 2019, the company was succeeded by Janssen-Cilag, a subsidiary of Johnson & Johnson.

**What identifiers are associated with Actelion Pharmaceuticals CZ?**
Key identifiers include the Czech Registration ID (IČO) 28998871, OpenCorporates ID cz/28998871, and Ringgold ID 56745.

## Why It Matters
Actelion Pharmaceuticals CZ played a role in the pharmaceutical industry within the Czech Republic, contributing to the local and regional healthcare ecosystem. As part of the Actelion network, it was involved in the development, distribution, or marketing of pharmaceutical products, addressing medical needs and advancing healthcare solutions. Its transition to Janssen-Cilag reflects the dynamic nature of the pharmaceutical sector, where mergers, acquisitions, and restructuring are common to enhance research, development, and market reach. The company’s operations in Prague also highlight the Czech Republic’s growing significance as a hub for pharmaceutical and biotechnological industries in Central Europe.

## Notable For
- **Limited Liability Structure:** Operated under the Czech legal form společnost s ručením omezeným, a common structure for businesses in the country.
- **Pharmaceutical Contributions:** Part of the Actelion Pharmaceuticals network, known for its focus on innovative therapies, particularly in cardiopulmonary diseases.
- **Strategic Location:** Headquartered in Prague, a key city in Central Europe with a growing life sciences sector.
- **Transition to Janssen-Cilag:** The company’s dissolution and succession by Janssen-Cilag mark a significant shift in its operational legacy, integrating it into a larger global pharmaceutical entity.
- **Unique Identifiers:** Associated with specific business identifiers, including the Czech Registration ID (IČO) and OpenCorporates ID, which are critical for legal and corporate tracking.

## Body

### History and Timeline
Actelion Pharmaceuticals CZ was established on **November 30, 2009**, as a limited liability company (společnost s ručením omezeným) in the Czech Republic. It operated under the official name **Actelion Pharmaceuticals CZ, s.r.o.** and was headquartered in **Prague** at **Francouzská 28, 120 00**. The company was part of the broader **Actelion Pharmaceuticals** network, a Swiss biopharmaceutical company known for its focus on innovative therapies, particularly in the areas of cardiopulmonary diseases.

The company ceased operations in **2019**, marking the end of its independent existence. Following its dissolution, it was succeeded by **Janssen-Cilag**, a subsidiary of **Johnson & Johnson**, indicating a strategic shift in ownership and operational focus.

### Legal and Corporate Structure
Actelion Pharmaceuticals CZ was structured as a **společnost s ručením omezeným (s.r.o.)**, a legal form equivalent to a limited liability company in Czech law. This structure is commonly used in the Czech Republic for businesses seeking to limit the liability of their owners while maintaining operational flexibility.

Key corporate identifiers associated with the company include:
- **Czech Registration ID (IČO):** 28998871
- **OpenCorporates ID:** cz/28998871
- **Ringgold ID:** 56745

These identifiers are essential for legal, financial, and regulatory tracking within the Czech Republic and internationally.

### Headquarters and Location
The company’s headquarters were located in **Prague**, the capital and largest city of the Czech Republic. The specific address was **Francouzská 28, 120 00**, placing it in a central and strategically important location within the city. Prague is a significant hub for business, research, and healthcare in Central Europe, making it an ideal location for a pharmaceutical company.

### Relationship to Actelion Pharmaceuticals and Janssen-Cilag
Actelion Pharmaceuticals CZ was part of the **Actelion Pharmaceuticals** network, a Swiss company founded in 1997 and known for its focus on developing treatments for cardiopulmonary diseases, including pulmonary arterial hypertension (PAH). Actelion was acquired by **Johnson & Johnson** in 2017, leading to the integration of its operations, including its Czech subsidiary, into the broader Janssen Pharmaceuticals network.

Following the dissolution of Actelion Pharmaceuticals CZ in 2019, its operations and assets were succeeded by **Janssen-Cilag**, a Johnson & Johnson subsidiary specializing in pharmaceutical research, development, and commercialization. This transition reflects the broader consolidation and restructuring within the pharmaceutical industry, where smaller or regional entities are often absorbed into larger global networks to streamline operations and enhance research capabilities.

### Role in the Pharmaceutical Industry
As part of the Actelion network, Actelion Pharmaceuticals CZ contributed to the development, distribution, or marketing of pharmaceutical products, particularly those targeting cardiopulmonary conditions. The company’s presence in the Czech Republic underscored the country’s growing role in the European pharmaceutical and biotechnology sectors, which benefit from a skilled workforce, robust research infrastructure, and strategic geographic location.

### Dissolution and Succession
The dissolution of Actelion Pharmaceuticals CZ in 2019 marked the end of its independent operations. The company’s assets, intellectual property, and ongoing projects were transitioned to **Janssen-Cilag**, ensuring continuity in research, development, and commercial activities. This succession aligns with Johnson & Johnson’s broader strategy of integrating acquired entities into its existing pharmaceutical divisions to leverage synergies and enhance global reach.

### Identifiers and Corporate Tracking
Actelion Pharmaceuticals CZ is associated with several unique identifiers that facilitate corporate tracking and regulatory compliance:
- **Czech Registration ID (IČO):** 28998871 – A unique identifier assigned to businesses registered in the Czech Republic.
- **OpenCorporates ID:** cz/28998871 – A global identifier used to track corporate entities across jurisdictions.
- **Ringgold ID:** 56745 – A proprietary identifier used in academic and research contexts to track organizational affiliations.

These identifiers are critical for legal documentation, financial reporting, and corporate governance, ensuring transparency and accountability in the company’s operations.

### Connection to the Czech Republic
The Czech Republic, where Actelion Pharmaceuticals CZ was based, is a Central European country known for its strong industrial base, skilled labor force, and growing life sciences sector. The country’s membership in the **European Union** and its strategic location make it an attractive destination for pharmaceutical and biotechnology companies. Actelion Pharmaceuticals CZ’s presence in Prague contributed to the local economy and reinforced the city’s reputation as a center for healthcare innovation.

### Legacy and Impact
Although Actelion Pharmaceuticals CZ operated for a relatively short period (2009–2019), its contributions to the pharmaceutical industry in the Czech Republic were significant. The company’s integration into Janssen-Cilag ensured that its research, development, and commercial efforts continued under a larger, more resource-rich organization. This transition highlights the dynamic nature of the pharmaceutical industry, where mergers and acquisitions are common strategies to drive innovation and expand market reach.

### Related Entities
- **Actelion Pharmaceuticals:** The Swiss parent company known for its focus on cardiopulmonary therapies.
- **Janssen-Cilag:** The successor entity, a Johnson & Johnson subsidiary specializing in pharmaceutical research and development.
- **Johnson & Johnson:** The global healthcare conglomerate that acquired Actelion Pharmaceuticals in 2017.
- **Prague:** The capital city of the Czech Republic and the headquarters location of Actelion Pharmaceuticals CZ.

### Database and Cataloging Information
Actelion Pharmaceuticals CZ is cataloged in various corporate and academic databases, including:
- **OpenCorporates:** A global database of corporate entities, where the company is listed under the ID cz/28998871.
- **Ringgold:** A proprietary database used for tracking organizational affiliations in academic and research contexts (ID: 56745).

These entries ensure that the company’s corporate history and transitions are documented and accessible for regulatory, financial, and research purposes.

## References

1. Aligned ISNI and Ringgold identifiers for institutions
2. Access to Registers of Economic Subjects